This smallcap pharma stock has zoomed 101% in a month

Shares of Morepen Laboratories, on Monday, were locked in 5 per cent upper circuit at Rs 68.65 on the BSE, hitting a 19-year high in an otherwise weak market. The pharmaceutical company's stock is trading at its highest level since May 2002, the BSE data shows.
Till 12:15 pm, a combined 8.2 million equity shares had changed hands and there were pending buy orders for 2.75 million shares on the NSE and BSE. In comparison, the S&P BSE Sensex was down 0.62 per cent at 48,481 points. In the past one month, the market price of Morepen Laboratories has zoomed 101 per cent, as compared to 3 per cent decline n the S&P BSE Sensex.

Related Keywords

Australia ,Japan ,United States ,India ,Himachal Pradesh ,Switzerland , ,Corinth Group ,Morepen Laboratories ,Active Pharmaceutical Ingredients ,Morepen Labs ,Home Diagnostics ,Oxygen Concentrators ,Morepen Laboratories Share Price ,Markets ,Dharma ,Orepen Kaboratories ,Orepen Kaboratories Latest News ,ஆஸ்திரேலியா ,ஜப்பான் ,ஒன்றுபட்டது மாநிலங்களில் ,இந்தியா ,இமாச்சல் பிரதேஷ் ,சுவிட்சர்லாந்து ,கொரிந்து குழு ,மேலும் ஆய்வகங்கள் ,செயலில் மருந்து பொருட்கள் ,வீடு பரிசோதனை ,ஆக்ஸிஜந் செறிவூட்டிகள் ,